Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10230/35778
dc.contributor.author | Makowski, Kamil |
---|---|
dc.contributor.author | Vigevani, Luisa, 1985- |
dc.contributor.author | Albericio, Fernando |
dc.contributor.author | Valcárcel, J. (Juan) |
dc.contributor.author | Álvarez, Mercedes |
dc.date | 2017 |
dc.identifier.citation | Makowski K, Vigevani L, Albericio F, Valcárcel J, Álvarez M. Sudemycin K: a synthetic antitumor splicing inhibitor variant with improved activity and versatile chemistry. ACS Chem Biol. 2017 Jan 20; 12(1): 163-173. DOI: 10.1021/acschembio.6b00562 |
dc.identifier.citation | 1554-8929 |
dc.identifier.citation | http://dx.doi.org/10.1021/acschembio.6b00562 |
dc.identifier.uri | http://hdl.handle.net/10230/35778 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | American Chemical Society (ACS) |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Chemical Biology, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/10.1021/acschembio.6b00562 |
dc.subject | Medicaments antineoplàstics |
dc.subject | Empalmament (Genètica) |
dc.subject | Medicaments -- Efectes secundaris |
dc.subject | Compostos spiro |
dc.subject | Química |
dc.title | Sudemycin K: a synthetic antitumor splicing inhibitor variant with improved activity and versatile chemistry |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract | |
dc.description.abstract |